Use of Mitomycin-C (MMC) in trabeculectomy
AAE-CT-USA-2010-02
Approved small_molecule completed
Quick answer
Use of Mitomycin-C (MMC) in trabeculectomy for Glaucoma is a Approved program (small_molecule) at AEON Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AEON Biopharma
- Indication
- Glaucoma
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed